In Medtronic Valleylab FT10 Energy Platform (VLFT10GEN) version 2.1.0 and lower and version 2.0.3 and lower, and Valleylab LS10 Energy Platform (VLLS10GEN—not available in the United States) version 1.20.2 and lower, the RFID security mechanism used for authentication between the FT10/LS10 Energy Platform and instruments can be bypassed, allowing for inauthentic instruments to connect to the generator.
In Medtronic Valleylab FT10 Energy Platform (VLFT10GEN) version 2.1.0 and lower and version 2.0.3 and lower, and Valleylab LS10 Energy Platform (VLLS10GEN—not available in the United States) version 1.20.2 and lower, the RFID security mechanism does not apply read protection, allowing for full read access of the RFID security mechanism data.
Medtronic Valleylab Exchange Client version 3.4 and below, Valleylab FT10 Energy Platform (VLFT10GEN) software version 4.0.0 and below, and Valleylab FX8 Energy Platform (VLFX8GEN) software version 1.1.0 and below use the descrypt algorithm for OS password hashing. While interactive, network-based logons are disabled, and attackers can use the other vulnerabilities within this report to obtain local shell access and access these hashes.
Medtronic Valleylab Exchange Client version 3.4 and below, Valleylab FT10 Energy Platform (VLFT10GEN) software version 4.0.0 and below, and Valleylab FX8 Energy Platform (VLFX8GEN) software version 1.1.0 and below use multiple sets of hard-coded credentials. If discovered, they can be used to read files on the device.
Medtronic MiniMed Insulin Pumps
are designed to communicate using a wireless RF with other devices, such as blood glucose meters, glucose sensor transmitters, and CareLink USB devices. This wireless RF communication protocol does not properly implement authentication or authorization. An attacker with adjacent access to one of the affected insulin pump models can inject, replay, modify, and/or intercept data. This vulnerability could also allow attackers to change pump settings and control insulin delivery.
The Conexus telemetry protocol utilized within Medtronic MyCareLink Monitor versions 24950 and 24952, CareLink Monitor version 2490C, CareLink 2090 Programmer, Amplia CRT-D, Claria CRT-D, Compia CRT-D, Concerto CRT-D, Concerto II CRT-D, Consulta CRT-D, Evera ICD, Maximo II CRT-D and ICD, Mirro ICD, Nayamed ND ICD, Primo ICD, Protecta ICD and CRT-D, Secura ICD, Virtuoso ICD, Virtuoso II ICD, Visia AF ICD, and Viva CRT-D does not implement encryption. An attacker with adjacent short-range access to a target product can listen to communications, including the transmission of sensitive data.
The Conexus telemetry protocol utilized within Medtronic MyCareLink Monitor versions 24950 and 24952, CareLink Monitor version 2490C, CareLink 2090 Programmer, Amplia CRT-D, Claria CRT-D, Compia CRT-D, Concerto CRT-D, Concerto II CRT-D, Consulta CRT-D, Evera ICD, Maximo II CRT-D and ICD, Mirro ICD, Nayamed ND ICD, Primo ICD, Protecta ICD and CRT-D, Secura ICD, Virtuoso ICD, Virtuoso II ICD, Visia AF ICD, and Viva CRT-D does not implement authentication or authorization. An attacker with adjacent short-range access to an affected product, in situations where the product’s radio is turned on, can inject, replay, modify, and/or intercept data within the telemetry communication. This communication protocol provides the ability to read and write memory values to affected implanted cardiac devices; therefore, an attacker could exploit this communication protocol to change memory in the implanted cardiac device.
Communications between Medtronic MiniMed MMT pumps and wireless accessories are transmitted in cleartext. A sufficiently skilled attacker could capture these transmissions and extract sensitive information, such as device serial numbers.
Medtronic MyCareLink Patient Monitor uses per-product credentials that are stored in a recoverable format. An attacker can use these credentials for network authentication and encryption of local data at rest.